Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors

Chiu, CY; Ahmed, S; Thomas, SK; Wang, LS; Mustafayev, K; Fayad, LE; Wierda, WG; Khawaja, F; Torres, HA

Torres, HA (通讯作者)，Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Div Internal Med, 1515 Holcombe Blvd,Unit 1460, Houston, TX 77030 USA.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023; 23 (8): 610

Abstract

Bruton tyrosine kinase (BTK) inhibitors are used to treat B-cell hematologic malignancies and may cause hepatitis B virus (HBV) reactivation. We retro......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索